Molecular mode of inhibition of glycogenolysis in rat liver by the dihydropyridine derivative, BAY R3401: Inhibition and inactivition of glycogen phosphorylase by an activated metabolite

Diabetes

Volumn 49, Issue 9, 2000, Pages 1419-1426

  Bergans, N ^a   Stalmans, W ^a   Goldmann, S ^a   Vanstapel, F ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BAY R3401; BAY U6751; BAY W1807; DIHYDROPYRIDINE DERIVATIVE; DISODIUM 4 (2 CHLOROPHENYL) 1 ETHYL 3 ISOPROPOXYCARBONYL 2 METHYL 1,4 DIHYDRO PYRIDINE 2,3 DICARBOXYLIC ACID; GLUCOSE 6 PHOSPHATE; GLYCOGEN PHOSPHORYLASE; GLYCOGEN SYNTHASE; ISOPROPYL 4 (2 CHLOROPHENYL) 1 ETHYL 2 METHYL 5 OXO 1,4,5,7 TETRAHYDRO FURO[3,4 B]PYRIDINE 3 CARBOXYLIC ACID; PHOSPHATASE; PRODRUG; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL TISSUE; ARTICLE; DEPHOSPHORYLATION; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME MECHANISM; GLYCOGENOLYSIS; METABOLITE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033850521     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.9.1419     Document Type: Article

References (52)

1. Inhibition of glycogenolysis enhances gluconeogenic precursor uptake by the liver of conscious dogs
2. Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo
3. Lilly lecture 1987: The triumvirate: β-cell, muscle, liver: A collusion responsible for NIDDM
4. Role of liver in pathophysiology of NIDDM
5. The glucose-lactic acid cycle and gluconeogenesis
6. Some thoughts on the importance of insulin in the regulation of the blood glucose level
7. Hepatic glucose metabolism and insulin resistance in NIDDM and obesity
8. Management of antidiabetic medications in overdose
9. The liver as a target for therapy in non-insulin dependent diabetes mellitus
10. Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans: A stable isotope study
11. Demonstration of a glycogen/glucose 1-phosphate cycle in hepatocytes from fasted rats: Selective inactivation of phosphorylase by 2-deoxy-2-fluoro-α-D-glucopyranosyl fluoride
12. Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans
13. Control of glycogen synthesis in health and disease
14. Glucose 6-phosphate plays a central role in the activation of glycogen synthase by glucose in hepatocytes
15. Glucose-induced glycogenesis in the liver involves the glucose-6-phosphate-dependent dephosphorylation of glycogen synthase
16. The control of liver glycogen synthetase phosphatase by phosphorylase
17. Phosphorylase a is an allosteric inhibitor of the glycogen and microsomal forms of rat hepatic protein phosphatase-1
18. The sequential inactivation of glycogen phosphorylase and activation of glycogen synthetase in liver after administration of glucose to mice and rats: The mechanism of the hepatic threshold to glucose
19. High-affinity binding of glycogen-synthase phosphatase to glycogen particles in the liver: Role of glycogen in the inhibition of synthase phosphatase by phosphorylase a
20. The effect of glucose and of potassium ions on the interconversion of the two forms of glycogen phosphorylase and of glycogen synthetase in isolated rat liver preparations
21. Synthase activation is not a prerequisite for glycogen synthesis in the starved liver
22. Hepatic phosphorylase deficiency: Its differentiation from other hepatic glycogenoses
23. Dextrothyroxine treatment of phosphorylase-kinase deficiency glycogenosis in four boys
24. The natural history of liver glycogenosis due to phosphorylase kinase deficiency: A longitudinal study of 41 patients
25. The family of glycogen phosphorylases: Structure and function
26. Design of inhibitors of glycogen phosphorylase: A study of α- and β-C-glucosides and 1-thio-β-D-glacose compounds
27. The structure of glycogen phosphorylase b with an alkyl-dihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor
28. Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1 4-dihydro-1-ethyl-2-methylpyridine-3,5,6, -tricarboxylate
29. An assessment of the importance of intralysosomal and ≃-amylolytic glycogenolysis in the liver of normal rats and of rats with a glycogen-storage disease
30. Kinetics of purified liver phosphorylase
31. The muscle phosphorylase b kinase reaction
32. The isolation and crystallization of rabbit skeletal muscle phosphorylase b
33. Drug solubilizers to aid pharmacologists: Amorphous cyclodextrin derivatives
34. Modulation of basal hepatic glycogenolysis by nitric oxide
35. Effects of glucose on phosphorylase and glycogen synthase in hepatocytes from diabetic rats
36. Effects of metabolic acidosis on viability of cells exposed to anoxia
37. The stimulation of liver phosphorylase b by AMP, fluoride and sulfate: A technical note on the specific determination of the a and b forms of liver glycogen phosphorylase
38. The catalytic activity of phosphorylase b in the liver: With a note on the assay in the glycogenolytic direction
39. Glycogen-synthase phosphatase activity in rat liver: Two protein components and their requirement for the activation of different types of substrate
40. Factors underlying significant underestimations of glucokinase activity in crude liver extracts: Physiological implications of higher cellular activity
41. A protein from rat liver confers to glucokinase the property of being antagonistically regulated by fructose 6-phosphate and fructose 1-phosphate
42. Assay of mannose-6-phosphatase in untreated and detergent-disrupted rat-liver microsomes for assessment of integrity of microsomal preparations
43. Determination of maltase and isomaltase activities with a glucoseoxidase reagent
44. 3.12 L-(+)-Lactate: L-(+)-2-hydroxypropanoic acid
45. Enzymatische Bestimmung der Brenztraubensaure (Pyruvat) im Blut ohne Enteiweiβung
46. Extracellullar metabolites in suspensions of isolated hepatocytes
47. 2.6. D-glucose 6-phosphate and D-fructose 6-phosphate: D-glacopyranose 6-phosphate and D-fructofuranose 6-phosphate
48. The hepatic glycogenolysis induced by reversible ischaemia or KCN is exclusively catalysed by phosphorylase a
49. Control of glycogen synthase by hierarchal protein phosphorylation
50. The interaction of phosphorylase a with D-glucose displays α-stereospecificity
51. Regulation of the dephosphorylation of glycogen phosphorylase a and synthase b by glucose and caffeine in isolated hepatocytes